Generics Lowering Part D Rx Costs, CMS Reports

AUGUST 01, 2006
p align=justify> Although critics of the new Medicare Part D drug benefit are pushing for changes in the program to lower costs to seniors, officials at the Centers for Medicare & Medicaid Services (CMS) contend that the program is already cutting prescription costs far more than originally expected.

According to CMS, strong competition among competing Part D prescription drug plans has enabled Medicare patients to see "deep discounts on their drugs at their local pharmacies," with much of the savings coming as a result of generic drugs. "In many cases, beneficiaries are using the unprecedented price information provided by Medicare to get much larger savings by switching to lower-cost drugs," CMS said. "Many beneficiaries?have switched to generic drugs, obtaining even deeper discounts on their drug costs."




SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.